Ammar Abdulrahman Jairoun

ChatGPT: Threat or boon to the future of pharmacy practice?

2023 · 16 Zit. · Research in Social and Administrative Pharmacy

Detecting manuscripts written by generative AI and AI-assisted technologies in the field of pharmacy practice

2024 · 10 Zit. · Journal of Pharmaceutical Policy and Practice

Benefit–Risk Assessment of ChatGPT Applications in the Field of Diabetes and Metabolic Illnesses: A Qualitative Study

2024 · 7 Zit. · Clinical Medicine Insights Endocrinology and Diabetes

Capturing pharmacists’ perspectives on the value, risks, and applications of ChatGPT in pharmacy practice: A qualitative study

2024 · 4 Zit. · Exploratory Research in Clinical and Social Pharmacy

Exploring the Value and Risks of Artificial Intelligence ChatGPT in Infectious Disease Management and Public Health: Regulatory Perspectives and Qualitative Insights

2024 · 0 Zit.

Author Response to Comment on: “Benefit–Risk Assessment of ChatGPT Applications in the Field of Diabetes and Metabolic Illnesses: A Qualitative Study”

2024 · 0 Zit. · Clinical Medicine Insights Endocrinology and Diabetes

Exploring the Value and Regulatory Perspectives of Artificial Intelligence ChatGPT in Pharmacoeconomic: A Qualitative Study on Benefits, Risks, and Stakeholder Beliefs

2024 · 0 Zit.